J. Steiner, L. J. Stovner, R. Jensen, D. Uluduz and Z. Katsarava, Review article | 13 February 2020Gut-brain Axis and migraine headache: a comprehensive reviewMahsa Arzani, Soodeh Razeghi Jahromi, Zeinab Ghorbani, Fahimeh Vahabizad, Paolo Martelletti, Amir Ghaemi, Simona Sacco and Mansoureh Togha, Research article | 7 April 2020Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central ItalyRaffaele Ornello, Alfonsina Casalena, Ilaria Frattale, Amleto Gabriele, Giannapia Affaitati, Maria Adele Giamberardino, Maurizio Assetta, Maurizio Maddestra, Fabio Marzoli, Stefano Viola, Davide Cerone, Carmine Marini, Francesca Pistoia and Simona Sacco, Research article | 1 June 2020A prospective real-world analysis of erenumab in refractory chronic migraineGiorgio Lambru, Bethany Hill, Madeleine Murphy, Ivona Tylova and Anna P. Andreou, Consensus article | 16 June 2020European headache federation consensus on the definition of resistant and refractory migraineSimona Sacco, Mark Braschinsky, Anne Ducros, Christian Lampl, Patrick Little, Antoinette Maassen van den Brink, Patricia Pozo-Rosich, Uwe Reuter, Elena Ruiz de la Torre, Margarita Sanchez Del Rio, Alexandra J. Sinclair, Zaza Katsarava and Paolo Martelletti, Research article | 13 October 2020Headache characteristics in COVID-19 pandemic-a survey studyzge Uygun, Mustafa Erta, Esme Ekizolu, Hayrunnisa Bolay, Aynur zge, Elif Kocasoy Orhan, Arif Atahan aatay and Betl Baykan, Research article | 2 March 2020Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) studyDawn C. Buse, Michael L. Reed, Kristina M. Fanning, Ryan Bostic, David W. Dodick, Todd J. Schwedt, Sagar Munjal, Preeti Singh and Richard B. Lipton, Research article | 29 July 2020Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort studyJavier Trigo, David Garca-Azorn, lvaro Planchuelo-Gmez, Enrique Martnez-Pas, Blanca Talavera, Isabel Hernndez-Prez, Gonzalo Valle-Peacoba, Paula Simn-Campo, Mercedes de Lera, Alba Chavarra-Miranda, Cristina Lpez-Sanz, Mara Gutirrez-Snchez, Elena Martnez-Velasco, Mara Pedraza, lvaro Sierra, Beatriz Gmez-Vicente,Juan Francisco Arenillasandngel L. Guerrero, Research article | 9 June 2020Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experienceAntonio Russo, Marcello Silvestro, Fabrizio Scotto di Clemente, Francesca Trojsi, Alvino Bisecco, Simona Bonavita, Alessandro Tessitore and Gioacchino Tedeschi, Research article | 24 September 2020Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey studyJasem Y. Al-Hashel and Ismail Ibrahim Ismail, Publication years: 2020-2021 Source: Web of Science, data collected: March 2023. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). The Journal of Headache and Pain | Home page PAIN received 4,288 citations in 2021. -, Who decides whether my work will be accepted? "In 2050, over 800 million people globally estimated to be living with back pain: Analysis also dispels common back pain myth." It considers the number of citations received by a journal and the importance of the journals from where these citations come. Visit the official website of the journal/conference to check the further details about the call for papers. Oh My Aching Back: Do Yoga, Tai Chi or Qigong Help? Roberta Messina, MD, PhD, is a headache specialist and researcher at the Scientific Institute and University Hospital San Raffaele in Milan, Italy. An image of a cartoon face that is very unhappy. An image of a cartoon face with a neutral expression. Media Ranking in Italy. Headache is a critical factor in increasing the global burden of disease ( 1 ), and tension-type headache (TTH) occurs in 42% of the adult population with an active headache disorder ( 2 ), which is a major factor that affects the disability-adjusted life-years of young and middle-aged people ( 3 ). An image of a cartoon face with an open mouth grin. The study analysed GBD data from 1990 to 2020 from over 204 countries and territories to map the landscape of back pain cases over time. ISSN stands for International Standard Serial Number. journal self-citations removed) received by a journal's published documents during the three previous years. Read more. In 2018, experts (independent to this study) voiced their concerns in The Lancet and gave recommendations, especially regarding exercise and education, about the need for a change in global policy on the best way to prevent and manage low back pain to stop the rise of inappropriate treatments. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address. Edited by Dr. Gianluca CoppolaThe Journal of Headache and Paininvites participating authors to submit to our Collection on Chronic Headaches and Medication Overuse. Language links are at the top of the page across from the title. Empirical evidence from population-based studies in nine disparate countries, Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study, In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers. It is also the first study to be used for modelling the future prevalence of back pain cases. Part of By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of pain and headache. Click here to find out more about the service, and your discount will be automatically applied when using this link. A systematic review and critical appraisal of randomized controlled trials, Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies, Metabolic profilechanges in serum of migraine patients detected using, Efficacy and safety of fremanezumab in clinical trial participants aged 60years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies, Total health insurance costs in children with a migraine diagnosis compared to a control group, Tracking tDCS induced grey matter changes in episodic migraine: a randomized controlled trial, Parenchymal neuroinflammatory signaling and dural neurogenic inflammation in migraine, Altered static and dynamic functional network connectivity in post-traumatic headache, The management and clinical knowledge of headache disorders among general practitioners in Norway: a questionnaire survey, Correction to: Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study, Pain sensitivity in men who have never experienced a headache: an observer blinded case control study, Real-world evidence data on the monoclonal antibody erenumab in migraine prevention: perspectives of treating physicians in Germany, Safety findings from CENTURION, a phase 3 consistency study of lasmiditan for the acute treatment of migraine, Correction to: Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study, Regional homogeneity alterations in multi-frequency bands in tension-type headache: a resting-state fMRI study, CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs, Differences in gray matter volume in episodic migraine patients with and without prior diagnosis or clinical care: a cross-sectional study, Minimal important change and responsiveness of the Migraine Disability Assessment Score (MIDAS) questionnaire, Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study, Risk for ischemic stroke and coronary heart disease associated with migraine and migraine medication among older adults, Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension, Angioarchitectural features amongst patients with unruptured brain arteriovenous malformations presenting with headache: findings from a single center retrospective review of 76 patients, Inflammatory complications of CGRP monoclonal antibodies: a case series, Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6months, Prenatal oestrogen-testosterone balance as a risk factor of migraine in adults, Intracranial pressure directly predicts headachemorbidity in idiopathic intracranial hypertension, Identification of disease- and headache-specific mediators and pathways in migraine using blood transcriptomic and metabolomic analysis, Correction to: Manual joint mobilisation techniques, supervised physical activity, psychological treatment, acupuncture and patient education for patients with tension-type headache. The Journal of Headache and Pain | Research - BioMed Central Current Pain and Headache Reports - Impact Factor, Overall Ranking The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. [32,7] Unfortunately, psychological factors are typically considered . Analysis of over 30 years of data has shown the number of cases of low back pain is growing, with modelling suggesting by 2050, 843 million people will be affected by the condition largely due to population increases and ageing of populations. Data Source: Scopus, Explore, visually communicate and make sense of data with our, Metrics based on Scopus data as of April 2023. Springer Science+Business Media, LLC, part of Springer Nature, Not logged in - 173.236.152.118. It is published by Springer-Verlag Italia Srl. 5-Year Impact Factor: 5.837 SUBMIT PAPER Cephalalgia contains original peer reviewed papers on all aspects of headache. -, General formatting rules for all article types Top 100 Journals With Impact Factor in 2022 (Highest To Lowest) SCImago Journal Rank is an indicator, which measures the scientific influence of journals. SUMMERSS: Vanda Felbab-Brown is a senior fellow at the Brookings Institution. All rights reserved. Global, regional, and national burden of low back pain, 1990-2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Their complicity is the subject of a number of lawsuits and news reporting that we don't have time to get into here, but you argue that this crisis can also be considered a geopolitical issue. Hence, it can provide a rough estimation only. Have any problems using the site? The landscape of back pain cases is set to shift, with the biggest increases in back pain cases to be in Asia and Africa. This thematic series aims to provide a collection of papers addressing the novel pathophysiology and developing neuroimaging-guided treatments for headache disorders. Impact-Faktor IF Analyse, Trend, Ranking & Vorhersage. This graph shows how the impact factor of Journal of Headache and Pain is computed. Springer Nature. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of pain and headache. ", "Older people have more complex medical histories and are more likely to be prescribed strong medication, including opioids for back pain management, compared to younger adults. The Journal of Headache and Pain - Wikipedia It is based on Scopus data. In 2020, there were approximately 619 million cases of back pain. The guidelines include . Journal of Headache and Pain Impact Factor: | Exaly But researchers say this study has confirmed that low back pain is more common among older people. Current Pain and Headache Reports | Home - Springer It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Note: The impact score shown here is equivalent to the average number of times documents published According to the Journal Citation Reports, the journal has a 2020 impact factor of 7.277.[1]. Published: 18 December 2021. For topics on particular articles, maintain the dialogue through the usual channels with your editor. According to SCImago Journal Rank (SJR), this journal is ranked 1.924. Low back pain remains the leading cause of YLDs globally, and in 2020, there were more than half a billion prevalent cases of low back pain worldwide. Challenges persist in obtaining primary country-level data on low back . The GBD is the most comprehensive picture of mortality and disability across countries, time, age, and. This journal has an h-index of 70. "Our analysis paints a picture of growing low back pain cases globally, putting enormous pressure on our healthcare system. It was established in 2000 and is published by BioMed Central. Journal of Headache and Pain is published by Springer-Verlag Italia Srl. ScienceDaily. It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. "Currently, how we have been responding to back pain has been reactive. Accuracy and availability may vary. An International Standard Serial Number (ISSN) is a unique code of 8 digits. After acceptance, we provide support so your article gains maximum impact in the scientific community and beyond. Journal of Headache and Pain. The two years line is equivalent to journal impact factor (Thomson Reuters) metric. Official Journal of the "European Headache Federation" and of "Lifting The Burden - The Global Campaign against Headache" Search within journal Volumes and issues Volume 24 December 2023 December 2023, issue 1 Volume 23 December 2022 December 2022, issue 1 December 2022, issue 1 16th European Headache Congress 2022 meeting abstracts The dominant research topics published in this journal include Migraine, Neurology, Internal medicine, Anesthesia and Psychiatry. Professor Ferreira says there is a lack of consistency in how health professionals manage back pain cases and how the healthcare system needs to adapt. Department of Clinical and Molecular Medicine. - 51.75.12.118. Journal of Oral & Facial Pain and Headache - Quintessenz Verlags-GmbH The left axis depicts the number of papers published in years X-1 and X-2 . It was established in 2000 and is published by BioMed Central. . The IS0 4 standard abbreviation of Journal of Headache and Pain is J. Headache Pain. -. Terms and Conditions, As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. MITPress. This collection will explore the latest research on the molecular and cellular mechanisms of migraine-associated neuroimmune interplay, as well as the clinical implications of these findings. In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. please visit the official website of this journal. Rank: Journal Title: Total Cites: Journal Impact Factor: 1: Cancer Journal For Clinicians: 55,868: 508.702: 2: Nature Reviews Molecular Cell Biology: 58,477: 94.444: 3: ScienceDaily, 23 May 2023. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. In 2022, nearly 110,000 Americans died from drug overdose, according to preliminary data from the CDC. It is the official journal of the European Headache Federation and Lifting The Burden. Manuela L Ferreira, Katie de Luca, Lydia M Haile, Jaimie D Steinmetz, Garland T Culbreth, Marita Cross, Jacek A Kopec, Paulo H Ferreira, Fiona M Blyth, Rachelle Buchbinder, Jan Hartvigsen, Ai-Min Wu, Saeid Safiri, Anthony D Woolf, Gary S Collins, Kanyin Liane Ong, Stein Emil Vollset, Amanda E Smith, Jessica A Cruz, Kai Glenn Fukutaki, Semagn Mekonnen Abate, Mitra Abbasifard, Mohsen Abbasi-Kangevari, Zeinab Abbasi-Kangevari, Ahmed Abdelalim, Aidin Abedi, Hassan Abidi, Qorinah Estiningtyas Sakilah Adnani, Ali Ahmadi, Rufus Olusola Akinyemi, Abayneh Tadesse Alamer, Adugnaw Zeleke Alem, Yousef Alimohamadi, Mansour Abdullah Alshehri, Mohammed Mansour Alshehri, Hosam Alzahrani, Saeed Amini, Sohrab Amiri, Hubert Amu, Catalina Liliana Andrei, Tudorel Andrei, Benny Antony, Jalal Arabloo, Judie Arulappan, Ashokan Arumugam, Tahira Ashraf, Seyyed Shamsadin Athari, Nefsu Awoke, Sina Azadnajafabad, Till Winfried Brnighausen, Lope H Barrero, Amadou Barrow, Akbar Barzegar, Lindsay M Bearne, Isabela M Bensenor, Alemshet Yirga Berhie, Bharti Bhandari Bhandari, Vijayalakshmi S Bhojaraja, Ali Bijani, Belay Boda Abule Bodicha, Srinivasa Rao Bolla, Javier Brazo-Sayavera, Andrew M Briggs, Chao Cao, Periklis Charalampous, Vijay Kumar Chattu, Flavia M Cicuttini, Benjamin Clarsen, Sarah Cuschieri, Omid Dadras, Xiaochen Dai, Lalit Dandona, Rakhi Dandona, Azizallah Dehghan, Takele Gezahegn G Demie, Edgar Denova-Gutirrez, Syed Masudur Rahman Dewan, Samath Dhamminda Dharmaratne, Mandira Lamichhane Dhimal, Meghnath Dhimal, Daniel Diaz, Mojtaba Didehdar, Lankamo Ena Digesa, Mengistie Diress, Hoa Thi Do, Linh Phuong Doan, Michael Ekholuenetale, Muhammed Elhadi, Sharareh Eskandarieh, Shahriar Faghani, Jawad Fares, Ali Fatehizadeh, Getahun Fetensa, Irina Filip, Florian Fischer, Richard Charles Franklin, Balasankar Ganesan, Belete Negese Belete Gemeda, Motuma Erena Getachew, Ahmad Ghashghaee, Tiffany K Gill, Mahaveer Golechha, Pouya Goleij, Bhawna Gupta, Nima Hafezi-Nejad, Arvin Haj-Mirzaian, Pawan Kumar Hamal, Asif Hanif, Netanja I Harlianto, Hamidreza Hasani, Simon I Hay, Jeffrey J Hebert, Golnaz Heidari, Mohammad Heidari, Reza Heidari-Soureshjani, Mbuzeleni Mbuzeleni Hlongwa, Mohammad-Salar Hosseini, Alexander Kevin Hsiao, Ivo Iavicoli, Segun Emmanuel Ibitoye, Irena M Ilic, Milena D Ilic, Sheikh Mohammed Shariful Islam, Manthan Dilipkumar Janodia, Ravi Prakash Jha, Har Ashish Jindal, Jost B Jonas, Gebisa Guyasa Kabito, Himal Kandel, Rimple Jeet Kaur, Vikash Ranjan Keshri, Yousef Saleh Khader, Ejaz Ahmad Khan, Md Jobair Khan, Moien AB Khan, Hamid Reza Khayat Kashani, Jagdish Khubchandani, Yun Jin Kim, Adnan Kisa, Jitka Klugarov, Ali-Asghar Kolahi, Hamid Reza Koohestani, Ai Koyanagi, G Anil Kumar, Narinder Kumar, Tea Lallukka, Savita Lasrado, Wei-Chen Lee, Yo Han Lee, Ata Mahmoodpoor, Jeadran N Malagn-Rojas, Mohammad-Reza Malekpour, Reza Malekzadeh, Narges Malih, Man Mohan Mehndiratta, Entezar Mehrabi Nasab, Ritesh G Menezes, Alexios-Fotios A Mentis, Mohamed Kamal Mesregah, Ted R Miller, Mohammad Mirza-Aghazadeh-Attari, Maryam Mobarakabadi, Yousef Mohammad, Esmaeil Mohammadi, Shafiu Mohammed, Ali H Mokdad, Sara Momtazmanesh, Lorenzo Monasta, Mohammad Ali Moni, Ebrahim Mostafavi, Christopher J L Murray, Tapas Sadasivan Nair, Javad Nazari, Seyed Aria Nejadghaderi, Subas Neupane, Sandhya Neupane Kandel, Cuong Tat Nguyen, Ali Nowroozi, Hassan Okati-Aliabad, Emad Omer, Abderrahim Oulhaj, Mayowa O Owolabi, Songhomitra Panda-Jonas, Anamika Pandey, Eun-Kee Park, Shrikant Pawar, Paolo Pedersini, Jeevan Pereira, Mario F P Peres, Ionela-Roxana Petcu, Mohammadreza Pourahmadi, Amir Radfar, Shahram Rahimi-Dehgolan, Vafa Rahimi-Movaghar, Mosiur Rahman, Amir Masoud Rahmani, Nazanin Rajai, Chythra R Rao, Vahid Rashedi, Mohammad-Mahdi Rashidi, Zubair Ahmed Ratan, David Laith Rawaf, Salman Rawaf, Andre M N Renzaho, Negar Rezaei, Zahed Rezaei, Leonardo Roever, Guilherme de Andrade Ruela, Basema Saddik, Amirhossein Sahebkar, Sana Salehi, Francesco Sanmarchi, Sadaf G Sepanlou, Saeed Shahabi, Shayan Shahrokhi, Elaheh Shaker, MohammadBagher Shamsi, Mohammed Shannawaz, Saurab Sharma, Maryam Shaygan, Rahim Ali Sheikhi, Jeevan K Shetty, Rahman Shiri, Siddharudha Shivalli, Parnian Shobeiri, Migbar Mekonnen Sibhat, Ambrish Singh, Jasvinder A Singh, Helen Slater, Marco Solmi, Ranjani Somayaji, Ker-Kan Tan, Rekha Thapar, Seyed Abolfazl Tohidast, Sahel Valadan Tahbaz, Rohollah Valizadeh, Tommi Juhani Vasankari, Narayanaswamy Venketasubramanian, Vasily Vlassov, Bay Vo, Yuan-Pang Wang, Taweewat Wiangkham, Lalit Yadav, Ali Yadollahpour, Seyed Hossein Yahyazadeh Jabbari, Lin Yang, Fereshteh Yazdanpanah, Naohiro Yonemoto, Mustafa Z Younis, Iman Zare, Armin Zarrintan, Mohammad Zoladl, Theo Vos, Lyn M March. Please do let us know if you need additional time. The dominant research topics published in this journal include . ACM If your research field is/are related to Anesthesiology and Pain Medicine (Q1); Medicine (miscellaneous) (Q1); Neurology (clinical) (Q1), then We urgently need more population-based back pain and musculoskeletal data from countries of low to mid-income," said senior author Professor Lyn March from Sydney Musculoskeletal Health and the Kolling Institute. As the opioid crisis . That's an average of about 300 people per day. The Journal of Headache and Pain | Volumes and issues - Springer Edited by Dr. MatildeLeonardi and Dr. PaoloMartellettiTheJournal of Headache and Painis calling for submissions to our Collection on One Health for Headache.
Canon Powershot Sx500, Ihop Donation Request, Graphql Batching Hackerone, Vello Low Profile Bubble Level, Articles J